Innovent Biologics, Inc. ( IVBXF) - Stock Earnings
IVBXF Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | 116.5 million USD | 831.0 million USD |
| 2025Q4 | -2.9 million USD | 996.3 million USD |
| 2026Q2 | 181.9 million USD | 1.3 billion USD |
IVBXF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -145.2 million USD | 876.7 million USD |
| 2024 | -13.0 million USD | 1.3 billion USD |
| 2025 | 113.3 million USD | 1.8 billion USD |
| 2026 Est. | — | — |
IVBXF
Price: $10.31
52 week price:
Earnings Per Share: 0.07 USD
P/E Ratio: 203.89
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 22.3 billion